Comparison Chart GC Cell Corporation

Equities

End-of-day quote Korea S.E. Other stock markets 23:00:00 23/05/2024 BST			5-day change	1st Jan Change
36,150 ^KRW	-0.55%		-1.77%	-20.55%

02-26	GC Cell and Biocentriq® Execute Process Transfer Agreement in Anticipation of the U.S. Entry of Immuncell-LC Inj	CI
01-08	GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	GC CELL CORPORATION	Medical & Diagnostic Laboratories	-0.55%	-1.77%	-20.55%	-20.46%	-2.30%	398M